Sermorelin

Sermorelin is the bioactive 1-29 amino acid fragment of human growth hormone-releasing hormone (GHRH). It is the original GHRH analog and was previously FDA-approved for pediatric GH deficiency.

Sermorelin is the most natural, most studied way to ask the pituitary to release its own growth hormone. It is the original GHRH analog — the great-grandparent of CJC-1295 and Tesamorelin.

Binds GHRH receptors on the pituitary somatotrophs, stimulating pulsatile release of endogenous GH. Because it preserves natural feedback, it avoids the supraphysiologic spikes of exogenous HGH.

Classic GHRH analog (29 amino acids). Mild, well-tolerated GH release.

1. Sermorelin
2. GHRH and/or ghrelin receptors in the pituitary
3. Pulsatile growth hormone release
4. Downstream IGF-1, body-composition and recovery endpoints

A plain-English read on how much published evidence currently exists for Sermorelin. These ratings describe the volume and maturity of the literature — not effectiveness, safety, or suitability for any use.

Current limitations: most compounds in this category are studied in preclinical or small-sample settings. Absence of large controlled human trials is the single biggest limitation to keep in mind when reading any summary of Sermorelin.

Lyophilized compounds are supplied as a dry powder. Concentration is simply the total amount in the vial divided by the volume of bacteriostatic water added:

Concentration (mg/mL) = total mg in vial ÷ mL of diluent added

Commonly supplied vial sizes

5mg, 9mg, or 15mg vial

Worked concentration example

5mg + 2mL BAC water → 2.5mg/mL On U-100 insulin syringe:

• • 8 units = 200mcg
• • 12 units = 300mcg
• • 20 units = 500mcg

Run your own numbers with the reconstitution calculator — it converts vial size and diluent volume into mg/mL and mcg/mL.

The figures below are reported here descriptively, because they are the values most frequently cited in publicly available research literature and reference material. They are not instructions, not a protocol, and not a recommendation. These compounds are supplied for laboratory research use only and are not approved by the FDA for human consumption.

Commonly cited amounts

200–500mcg before bed subcutaneous

Commonly cited frequency

Daily before bed (commonly 5 nights on, 2 off)

Commonly cited study duration

3–6 months

Peptides are supplied freeze-dried because peptide bonds degrade far faster in solution than in a dry state. Understanding storage is part of understanding why the powder form exists at all.

• •Lyophilized powder: stored refrigerated, typically stable for months to years.
• •Reconstituted solution: refrigerated at 2–8°C, generally discussed as stable for roughly 30–60 days.
• •Heat and direct light accelerate degradation — vials are kept cool and dark.
• •Reconstituted material is not re-frozen; ice crystal formation disrupts peptide structure.
• •Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which is what allows multi-day storage after reconstitution.

More detail in the storage & handling guide and how peptide quality is evaluated.

• •Pediatric and adult GH deficiency
• •Anti-aging and GH-restoration research
• •Sleep architecture studies
• •Comparison with CJC-1295 and Tesamorelin
• •Body composition research

Discussed in anti-aging clinics and biohacker forums as the 'gentle' GHRH analog. Threads compare it to CJC-1295 (longer half-life) and Tesamorelin (more potent).

“The original natural GH-release peptide.”

Commonly paired with Ipamorelin in 'Sermorelin + Ipamorelin' stacks for additive GH pulses. Often compared with CJC-1295/Ipamorelin and Tesamorelin.

Sermorelin is the bioactive 1-29 GHRH fragment studied for stimulating endogenous GH release while preserving natural feedback regulation.